User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Inhaled triple therapy in chronic obstructive pulmonary disease.

Primary tabs

Marchand, Eric [UCL]

(eng) In the TRIBUTE study,1 Alberto Papi and colleagues (March 17, p 1076) reported a small but significant reduction of the exacerbation rate with the addition of an inhaled corticosteroid to dual long-acting bronchodilation in patients with chronic obstructive pulmonary disease and severe or very severe airway obstruction with at least one exacerbation in the previous year. Data derived from the ISOLDE study [...]

Document type Article de périodique (Journal article) – Lettre à l'éditeur
Access type Accès interdit
Publication date 2018
Language Anglais
Journal information "Lancet (London, England)" - Vol. 392, no. 10153, p. 1112 (2018)
Peer reviewed yes
Publisher Elsevier ((United Kingdom) London)
issn 0140-6736
e-issn 1474-547X
Publication status Publié
Affiliations UCL - (MGD) Service de pneumologie
UCL - SSS/IREC/LUNS - Pôle pneumologie, ORL (airways) et dermatologie (skin)
Links
Bibliographic reference Marchand, Eric. Inhaled triple therapy in chronic obstructive pulmonary disease.. In: Lancet (London, England), Vol. 392, no. 10153, p. 1112 (2018)
Permanent URL http://hdl.handle.net/2078.1/204078